Session Learning Objectives

Those attending this session will receive information that should allow them to:

• Recognize and become familiar with new therapeutics being utilized in gynecologic cancers;
• Identify the basic mechanisms of PARP inhibitors, immunotherapy, and antibody drug conjugates;
• List some of the common side effects associated with PARP inhibitors, immunotherapy, and antibody drug conjugates; and
• Discuss the key benefits and rationale of new therapeutics in management of gynecologic cancers